Mesenbio

Developer of of therapeutic solutions for arthritis treatment

placeYork, England, United Kingdom calendar_todayFounded 2021 language mesenbio.net

Social engagement

Social engagement: 1.2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include DSW Ventures, Ngbio.

Investor typeCountShare
Venture capital2100%
Coming soon